Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M De Jonge

Showing results (91-100 of 158) with videos related to

Pageof 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiformeC Twelves, M Campone, B Coudert, et al.
Behavior Therapy|February 28, 2024
Evaluating the Effectiveness of Take it Personal!+ in People With Mild Intellectual Disability or Borderline Intellectual Functioning and Substance Use Disorder: A Multiple Baseline Single-Case Experimental StudyLotte C F Gosens, Evelien A P Poelen, Robert Didden, et al.
Gynecologic and Obstetric Investigation|September 2, 2004
Single-step maternal serum screening for trisomy 21 in the era of combined or integrated screeningWilfried J A Gyselaers, Annie J Vereecken, Erik van Herck, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2004
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development GroupG Giaccone, E F Smit, M de Jonge, et al.
Perfusion|June 28, 2014
Intermittent warm blood versus cold crystalloid cardioplegia for myocardial protection: a propensity score-matched analysis of 12-year single-center experienceM de Jonge, A G van Boxtel, M A Soliman Hamad, et al.
Nature|June 15, 2007
Exploitation of structural and regulatory diversity in glutamate racemasesTomas Lundqvist, Stewart L Fisher, Gunther Kern, et al.
British Journal of Cancer|September 30, 2010
A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumoursC M L van Herpen, F A L M Eskens, M de Jonge, et al.
Tijdschrift Voor Gerontologie En Geriatrie|November 13, 2013
[Managing concerns about falls in older people: evaluation of the implementation of an evidence-based program]G A R Zijlstra, M F M T Du Moulin, J C M van Haastregt, et al.
Antimicrobial Agents and Chemotherapy|September 24, 2014
A novel high-throughput cell-based assay aimed at identifying inhibitors of DNA metabolism in bacteriaJun Fan, Boudewijn L M de Jonge, Kathy MacCormack, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|October 2, 2004
Audit on nuchal translucency thickness measurements in Flanders, Belgium: a plea for methodological standardizationW J A Gyselaers, A J Vereecken, E J H Van Herck, et al.
Pageof 16

Showing results (91-100 of 158) with videos related to

Sort By:
Pageof 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiformeC Twelves, M Campone, B Coudert, et al.
Behavior Therapy|February 28, 2024
Evaluating the Effectiveness of Take it Personal!+ in People With Mild Intellectual Disability or Borderline Intellectual Functioning and Substance Use Disorder: A Multiple Baseline Single-Case Experimental StudyLotte C F Gosens, Evelien A P Poelen, Robert Didden, et al.
Gynecologic and Obstetric Investigation|September 2, 2004
Single-step maternal serum screening for trisomy 21 in the era of combined or integrated screeningWilfried J A Gyselaers, Annie J Vereecken, Erik van Herck, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2004
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development GroupG Giaccone, E F Smit, M de Jonge, et al.
Perfusion|June 28, 2014
Intermittent warm blood versus cold crystalloid cardioplegia for myocardial protection: a propensity score-matched analysis of 12-year single-center experienceM de Jonge, A G van Boxtel, M A Soliman Hamad, et al.
Nature|June 15, 2007
Exploitation of structural and regulatory diversity in glutamate racemasesTomas Lundqvist, Stewart L Fisher, Gunther Kern, et al.
British Journal of Cancer|September 30, 2010
A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumoursC M L van Herpen, F A L M Eskens, M de Jonge, et al.
Tijdschrift Voor Gerontologie En Geriatrie|November 13, 2013
[Managing concerns about falls in older people: evaluation of the implementation of an evidence-based program]G A R Zijlstra, M F M T Du Moulin, J C M van Haastregt, et al.
Antimicrobial Agents and Chemotherapy|September 24, 2014
A novel high-throughput cell-based assay aimed at identifying inhibitors of DNA metabolism in bacteriaJun Fan, Boudewijn L M de Jonge, Kathy MacCormack, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|October 2, 2004
Audit on nuchal translucency thickness measurements in Flanders, Belgium: a plea for methodological standardizationW J A Gyselaers, A J Vereecken, E J H Van Herck, et al.
Pageof 16